Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Peritoneal Neoplasms|Ovarian Neoplasms|Pancreatic Neoplasms|Stomach Neoplasms
Interventions: OTHER: ²¹²Pb-TCMC-Trastuzumab|BIOLOGICAL: trastuzumab
Sponsor: Orano Med LLC